tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Innoviva price target raised to $45 from $40 at H.C. Wainwright
PremiumThe FlyInnoviva price target raised to $45 from $40 at H.C. Wainwright
3M ago
Innoviva Reports Strong Q2 2025 Financial Results
Premium
Company Announcements
Innoviva Reports Strong Q2 2025 Financial Results
3M ago
Innoviva reports Q2 EPS 77c vs. (55c) last year
Premium
The Fly
Innoviva reports Q2 EPS 77c vs. (55c) last year
3M ago
Innoviva Specialty Therapeutics announces FDA accepts NDA for zoliflodacin
PremiumThe FlyInnoviva Specialty Therapeutics announces FDA accepts NDA for zoliflodacin
5M ago
Innoviva Elects Board Members and Approves Compensation
Premium
Company Announcements
Innoviva Elects Board Members and Approves Compensation
5M ago
Innoviva subsidiary announces U.S. commercial availability of ZEVTERA
Premium
The Fly
Innoviva subsidiary announces U.S. commercial availability of ZEVTERA
5M ago
Innoviva initiated with an Outperform at Scotiabank
PremiumThe FlyInnoviva initiated with an Outperform at Scotiabank
8M ago
INVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
Innoviva enters distribution, license agreement with Basilea for Zevtera
Premium
The Fly
Innoviva enters distribution, license agreement with Basilea for Zevtera
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100